Literature DB >> 29016563

CON: Hepatocellular Carcinoma Surveillance: In Need of Higher-Quality Data.

Amit G Singal1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29016563     DOI： 10.1038/ajg.2017.374

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  11 in total

1.  Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?

Authors:  K G Marshall
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

Review 2.  Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review.

Authors:  Amit G Singal; Adam Yopp; Celette S Skinner; Milton Packer; William M Lee; Jasmin A Tiro
Journal:  J Gen Intern Med       Date:  2012-01-04       Impact factor: 5.128

3.  Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?

Authors:  Hossein Poustchi; Geoffrey C Farrell; Simone I Strasser; Alice U Lee; Geoffrey W McCaughan; Jacob George
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

4.  An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  Omair Atiq; Jasmin Tiro; Adam C Yopp; Adam Muffler; Jorge A Marrero; Neehar D Parikh; Caitlin Murphy; Katharine McCallister; Amit G Singal
Journal:  Hepatology       Date:  2016-12-19       Impact factor: 17.425

5.  Ten-year risk of false positive screening mammograms and clinical breast examinations.

Authors:  J G Elmore; M B Barton; V M Moceri; S Polk; P J Arena; S W Fletcher
Journal:  N Engl J Med       Date:  1998-04-16       Impact factor: 91.245

6.  Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  O Simmons; D T Fetzer; T Yokoo; J A Marrero; A Yopp; Y Kono; N D Parikh; T Browning; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2016-11-08       Impact factor: 8.171

7.  Modeling the benefits and harms of surveillance for hepatocellular carcinoma: Information to support informed choices.

Authors:  Eleanor J Taylor; Rebecca L Jones; J Ashley Guthrie; Ian A Rowe
Journal:  Hepatology       Date:  2017-10-11       Impact factor: 17.425

8.  Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.

Authors:  Clement K Gwede; Stacy N Davis; Shaenelle Wilson; Mitul Patel; Susan T Vadaparampil; Cathy D Meade; Brian M Rivers; Daohai Yu; Javier Torres-Roca; Randy Heysek; Philippe E Spiess; Julio Pow-Sang; Paul Jacobsen
Journal:  Am J Health Promot       Date:  2014-06-26

Review 9.  Impact of Changes to Breast Cancer Screening Guidelines on Healthcare Providers and Patients.

Authors:  Erin Hartnett
Journal:  Clin J Oncol Nurs       Date:  2016-04       Impact factor: 1.027

10.  Randomized controlled trial of screening for hepatocellular carcinoma.

Authors:  Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553
View more
  2 in total

1.  Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.

Authors:  Neehar D Parikh; Nabihah Tayob; Taim Al-Jarrah; Jennifer Kramer; Jennifer Melcher; Donna Smith; Patrick Marquardt; Po-Hong Liu; Runlong Tang; Fasiha Kanwal; Amit G Singal
Journal:  JAMA Netw Open       Date:  2022-07-01

2.  Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer-specific and overall mortality: A modeling approach.

Authors:  Massih Ningarhari; Abbas Mourad; Claire Delacôte; Line-Carolle Ntandja Wandji; Guillaume Lassailly; Alexandre Louvet; Sébastien Dharancy; Philippe Mathurin; Sylvie Deuffic-Burban
Journal:  Hepatol Commun       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.